DBD Diebold Nixdorf, Incorporated CALCULATING & ACCOUNTING MACHINES (NO ELECTRONIC COMPUTERS) Best Software Stocks 2026 →

Diebold Nixdorf (DBD) Stock: Buy, Sell, or Hold?

$57.34
-2.75 (-4.58%) ▼
5d: +2.72% 30d: -9.36% 90d: -20.12%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (89%)
Quality Score
53/100
Position
OVERSOLD
30-Day Fair Range
$58.51 – $67.61
Position: OVERSOLD
Forward P/E & Valuation
9.3x CHEAP
vs 11.5x historical avg
Wall Street Target
$85.00
+48.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$52.87 / $62.08
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: DBD shows positive signals but monitor for confirmation. Market pricing in 6.7% decline. Moderate conviction.

Get Alerted When DBD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$137.43
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$85.33
32.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: DBD is currently trading at $57.34, which is considered oversold relative to its 30-day fair value range of $58.51 to $67.61. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.3) compared to its historical average (11.5). Remarkably, the market is currently pricing in an annual earnings decline of 6.7% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, DBD is in a strong downtrend. Immediate support is located at $52.87, while resistance sits at $62.08. Short-term momentum is weak, with the stock down 4.6% recently.

Market Sentiment: DBD scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $85.00 (+48.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $58.51 - $67.61
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 88.5%

Trading Range & Key Levels

30-Day Trading Range $58.51 - $67.61
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$2.82 (4.9%)
Support Level $52.87
Resistance Level $62.08
Current Trend Strong Downtrend
Technical data as of Nov 10, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (67/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.6%)
  • BULLISH: Trading 48.2% below Wall St target ($85.00)
  • BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up

Fundamental Context

Forward P/E (Next Year Est.) 9.34
Wall Street Target $85.00 (+48.2%)
Revenue Growth (YoY) 5.2%
Earnings Growth (YoY) -82.9%
Profit Margin 2.0%
Valuation Discount vs History -6.7% cheaper
PE vs Historical 9.3 vs 11.5 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -6.7% (market-implied from PE analysis)
1-Year Target $53.50 (-7%)
2-Year Target $49.91 (-13%)
3-Year Target $46.57 (-19%)
3-Yr Target (if PE normalizes) (PE: 9→12) $57.32 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 31.2%) $275.36 (+380%)
Base: (SPY PE: 9.3, Growth: 31.2%) $129.55 (+126%)
Bear: (PE: 7.9, Growth: 31.2%) $110.12 (+92%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 28.48 | Current EPS (TTM): $2.11
Bull Case $132.20 (+131%)
Analyst growth 100.0%, PE expands to 31.3
Base Case $120.18 (+110%)
Market implied 100.0%, PE stable at 28.5
Bear Case $40.86 (-29%)
Severe decline -20.0%, PE contracts to 24.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.3 to 11.5
Stabilization Target: $70.57 (+23.1%)
PE Expansion Potential: +23.1%
Share DBD Analysis

Share this live DBD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (DBD)

Bearish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 30, 2026
Daily AI digest
AI Retail Discussion Summary: A bearish StockTwits user claims $DBD engaged in manipulative practices after emerging from bankruptcy, purchasing their own shares to artificially inflate the price.
Key Retail Themes: company manipulation past bankruptcy
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:24 AM ET
Data refreshes hourly during market hours. Next update: 8:24 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for DBD.

Create Free Account

Already have an account? Log In

Top Rated Software - Application Stocks

Top-rated stocks in Software - Application by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NOW
ServiceNow Inc
STRONG BUY
49 analysts
$156 56 HOLD
SHOP
Shopify Inc
STRONG BUY
55 analysts
$177 65 BUY
DT
Dynatrace Holdings LLC
STRONG BUY
37 analysts
$61 49 HOLD
TEAM
Atlassian Corp Plc
STRONG BUY
33 analysts
$230 33 SELL
ADSK
Autodesk Inc
STRONG BUY
36 analysts
$308 34 SELL

Advanced DBD Option Strategies

Professional options setups generated by AI based on today's DBD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive DBD Research Pages
DBD Technical Chart DBD Price Prediction DBD Intrinsic Value DCF DBD Earnings Date Why is DBD Moving Today? DBD Investment Advisor DBD Fair Price Analyzer DBD Options Chain DBD Options Advisor DBD Options Analysis DBD Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals